Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes
Alessandro Di Federico, Mirta Mosca, Rachele Pagani, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2429-2429
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types
Junho Kang, Jun Hyeong Lee, Hongui Cha, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Exploring CAR-macrophages in non-tumor diseases: Therapeutic potential beyond cancer
Yizhao Chen, Qianling Xin, Mengjuan Zhu, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
The Landmark Series: The Future of Pancreatic Cancer Clinical Trials
Yongwoo David Seo, Matthew H. G. Katz, Rebecca A. Snyder
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2777-2785
Closed Access | Times Cited: 1
Preclinical study of inetetamab combined with atezolizumab to synergistically inhibit HER2 and PD-L1 in the treatment of ovarian cancer
Feiquan Ying, Xuyang Zhou, Mengqing Chen, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200938-200938
Open Access | Times Cited: 1
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarak Chouari, Francesca Soraya La Costa, Nabeel Merali, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4265-4265
Open Access | Times Cited: 22
Drug Delivery Strategies for the Treatment of Pancreatic Cancer
Oluwabukunmi Olajubutu, Omotola D. Ogundipe, Amusa S. Adebayo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1318-1318
Open Access | Times Cited: 18
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Joanna Ciepła, Ryszard Smolarczyk
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models
Yuncang Yuan, Jiawei Fan, Dandan Liang, et al.
Translational Oncology (2023) Vol. 39, pp. 101803-101803
Open Access | Times Cited: 13
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 22
“Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug”
Amanda R. Decker-Farrell, Stephen A. Sastra, Tetsuhiro Harimoto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment
Nikolaos Vitorakis, Antonios N. Gargalionis, Kostas A. Papavassiliou, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2876-2876
Open Access | Times Cited: 4
Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Masaaki Nishi, Shoko Yamashita, Chie Takasu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models
Virginia Metrangolo, Mylan Blomquist, Ananya Dutta, et al.
Science Advances (2025) Vol. 11, Iss. 3
Open Access
Withania somnifera-Derived Phytochemicals as Bcl-B Inhibitors in Cancer Therapy: A Computational Approach from Byte to Bench to Bedside
D. S. Dhillon, Monika Jain, Amit Kumar Singh, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151383-151383
Closed Access
Proteogenomic analysis reveals Arp 2/3 complex as a common molecular mechanism in high risk pancreatic cysts and pancreatic cancer
A. K. M. Firoj Mahmud, Dina Gamaleldin Mansour Aly, Yelin Zhao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Mechanisms behind the LncRNAs-mediated regulation of paclitaxel (PTX) resistance in human malignancies
Ali G. Alkhathami, Harikumar Pallathadka, Sejal Shah, et al.
Experimental Cell Research (2025), pp. 114434-114434
Closed Access
Knowledge, attitudes, and practices regarding whole-course management among patients with gastrointestinal cancers: a cross-sectional study
Min Huang, Lei Feng, Huiling Ren, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Ammonia-induced lysosomal and mitochondrial damage: a novel perspective on T cell-based cancer immunotherapy
Jianqiao Shentu, Hening Xu, Feng Zhu
Journal of the National Cancer Center (2025) Vol. 5, Iss. 2, pp. 105-107
Open Access
Optimal early endpoint for second-line or subsequent immune checkpoint inhibitors in previously treated advanced solid cancers: a systematic review
Jingqiu Li, Xiaoding Zhou, Lei Wu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis
Aiarpi Ezdoglian, M. Tsang-A-Sjoe, Fatemeh Khodadust, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Is ADC a rising star in solid tumor? An umbrella review of systematic reviews and meta-analyses
Hua Wei, Yongjun Zhang, Yunlong Lu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Cardiotoxicity induced by chemotherapy and immunotherapy in cancer treatment: a bibliometric analysis
Xi Zhang, Yanfeng Xue, Mingyan Hao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Innovative Smart Biosensors for Cancer Theranostics: A New Frontier in Detection, Diagnosis, and Beyond
Archna Dhasmana, Amutha Santhanam, Khushi Dhasmana, et al.
Cancer Treatment and Research Communications (2025), pp. 100911-100911
Open Access
Comprehensive analysis of UPK3B as a marker for prognosis and immunity in pancreatic adenocarcinoma
Ziying Jian, Tao Pan, Renjie Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Interplay Between DNA Repair and the Immune Microenvironment in Pancreatic Cancer
Aaron Ciner, Peter J. Hosein, Yixing Jiang, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1031-1031
Open Access
Page 1 - Next Page

Scroll to top